Front PageNational News Pakistan
Send News Request
Tech•International Bureau•20 Nov 2026, 01:51 PM PKT•2 min read•1,865 Reads

AI Revolutionizes Drug Discovery Timelines for Big Pharma

Drug makers use AI to design molecules, identify promising candidates and detect safety risks. National News Pakistan correspondents report that administrative desks and on-ground observers are closely monitoring developments across Pakistan.

60-Second Editorial Quick Summaryخلاصہ

Verified facts & intelligence briefed by National News Press Bureau.

stage drug development at major pharmaceutical companies this year, reducing the time required to produce new molecules and transition them into clinical trials by as much as 50%.

According to field observations and verified reporting compiled by the International bureau desk: Leading firms such as GSK, Bristol Myers Squibb, Novartis, Eli Lilly, Novo Nordisk, AstraZeneca, and Sanofi have transitioned from traditional tasks to utilizing AI for more complex processes, including molecule design and safety risk identification.

AstraZeneca's executive, Sharon Barr, emphasized that AI is now integral to every stage of the drug discovery and development pipeline.

NNP Central Editorial Research Desk
#Pakistan National Bureau#Tech Desk
WhatsApp𝕏 PostFacebook
AI Revolutionizes Drug Discovery Timelines for Big Pharma
Photo: National News Pakistan Bureau

INTERNATIONAL BUREAU —stage drug development at major pharmaceutical companies this year, reducing the time required to produce new molecules and transition them into clinical trials by as much as 50%.

According to field observations and verified reporting compiled by the International bureau desk: Leading firms such as GSK, Bristol Myers Squibb, Novartis, Eli Lilly, Novo Nordisk, AstraZeneca, and Sanofi have transitioned from traditional tasks to utilizing AI for more complex processes, including molecule design and safety risk identification. AstraZeneca's executive, Sharon Barr, emphasized that AI is now integral to every stage of the drug discovery and development pipeline. The shift towards AI in drug discovery has been marked by a series of strategic moves from these pharmaceutical giants.

Technological correspondents and telecom policy specialists underscore that rapid digital infrastructure deployment, PTA cyber compliance protocols, and national data security guidelines remain vital benchmarks shaping sector performance across Pakistan.

Civil society representatives and local community members in International have urged administrative authorities to ensure transparent communication and rapid service delivery to address citizen requirements effectively.

The Central Editorial Desk of National News Press continues to monitor on-ground developments in real time, with verified updates and formal departmental communiqués to be published as official notifications are finalized.

Key Takeaways & Executive Analysis

  • stage drug development at major pharmaceutical companies this year, reducing the time required to produce new molecules and transition them into clinical trials by as much as 50%.
  • According to field observations and verified reporting compiled by the International bureau desk: Leading firms such as GSK, Bristol Myers Squibb, Novartis, Eli Lilly, Novo Nordisk, AstraZeneca, and Sanofi have transitioned from traditional tasks to utilizing AI for more complex processes, including molecule design and safety risk identification.
  • AstraZeneca's executive, Sharon Barr, emphasized that AI is now integral to every stage of the drug discovery and development pipeline.
Verified National Coverage: Published by National News Press (International Bureau). Fact-checked and verified.
Verified Editorial Desk
WhatsApp𝕏 PostFacebook

Audience Reviews & Discussion

Share your perspective, rate coverage accuracy, and engage with verified readers across Pakistan.

Rate This Story

Join the Discussion

Civic discussion moderated by NNP Editorial Desk

Community Comments (0)